RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$72.75
Why RxSight (RXST) Shares Are Falling
RxSight Inc (NASDAQ:RXST) shares are roughly flat following earlier weakness during Thursday's session after the company announced pricing of its $100 million proposed public offering of common stock.
RxSight Price Raises Equity at $56 per Share
Express News | Reported Earlier, RxSight Prices Public Offering Of 1,785,714 Common Stock At $56/Share
RxSight To Sell About 1.79 Mln Shares At $56.00/shr; Stock Down
Express News | Rxsight Inc - Expects to Sell 1.8 Mln Shares of Its Common Stock at a Price to Public of $56.00 per Share
Express News | Rxsight, Inc. Announces Pricing of Public Offering of Common Stock
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
Express News | RxSight Shares Are Trading Lower After the Company Announced a $100 Million Proposed Public Offering of Common Stock
RxSight Shares Are Trading Lower After the Company Announced a $100 Million Proposed Public Offering of Common Stock.
RxSight Shares Are Trading Lower After the Company Announced a $100 Million Proposed Public Offering of Common Stock.
RxSight Announces $100M Proposed Public Offering Of Common Stock
RxSight, Inc., (NASDAQ:RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced today that it intends to offe
RxSight Announces Proposed Offering of Common Stock
Express News | Rxsight: Intends to Offer & Sell $100 Mln of Shares of Common Stock in Underwritten Public Offering
RxSight Files Automatic Mixed Shelf
Express News | Rxsight, Inc. Announces Proposed Public Offering of Common Stock
Press Release: RxSight, Inc. Announces Proposed Public Offering of Common Stock
RxSight, Inc. Announces Proposed Public Offering of Common Stock ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., (Nasdaq: RXST), an ophthalmic medical device company dedicated to
RxSight, Inc. Announces Proposed Public Offering of Common Stock
ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following
Express News | Rxsight Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing
RxSight's Strong Q1 Performance and Market Expansion Justify Buy Rating
RxSight Is Maintained at Overweight by Wells Fargo
RxSight Is Maintained at Overweight by Wells Fargo
No Data